Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer
Passildas‐Jahanmohan, Judith, Eymard, Jean‐Christophe, Pouget, Mélanie, Kwiatkowski, Fabrice, Van Praagh, Isabelle, Savareux, Laurent, Atger, Marc, Durando, Xavier, Abrial, Catherine, Richard, Damien, Ginzac Couvé, Angeline, Thivat, Emilie, Monange, Brigitte, Chollet, Philippe, Mahammedi, Hakim
Published in Cancer medicine (Malden, MA) (01.04.2021)
Published in Cancer medicine (Malden, MA) (01.04.2021)
Get full text
Journal Article
Docetaxel and curcuminoids (CCM) combination in patients with castration-resistant prostate cancer (CRPC): A phase II study
Mahammedi, Hakim, Pouget, Mélanie, Planchat, Eloise, Cure, Herve, Durando, Xavier, Bayet-Robert, Mathilde, Van-Praagh, Isabelle, Atger, Marc, Guy, Laurent, Abrial, Catherine, Chollet, Philippe J. M., Eymard, Jean-Christophe
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article